Managing haematology and oncology patients during the COVID- 19 pandemic: interim consensus guidance

A pandemic coronavirus, SARS- CoV- 2, causes COVID- 19, a potentially life- threatening respiratory disease. Patients with cancer may have compromised immunity due to their malignancy and/or treatment, and may be at elevated risk of severe COVID- 19. Community transmission of COVID- 19 could overwhelm health care services, compromising delivery of cancer care. This interim consensus guidance provides advice for clinicians managing patients with cancer during the pandemic.

Managing haematology and oncology patients during the COVID- 19 pandemic: interim consensus guidance
Size: 16.3 MB